Table 2.

Median progression-free survival and overall survival by initial chemotherapy regimen

First line chemotherapy	N	Median PFS (95% CI)	Median OS (95% CI)
No chemotherapy	3	1.3 (0.5–2.1)	1.3 (0.5–2.1)
Ifosfamide/Paclitaxel	7	8.0 (2.4–13.7)	19.0 (16.4–21.6)
Carboplatin/Paclitaxel	15	17.8 (4.0–31.6)	23.2 (22.0–24.4)
Ifosfamide/Cisplatin	4	13.0 (0.0–28.3)	20.6 (0.0–65.2)
Carboplatin/Cytoxan	1	13.4 (NA)	13.4 (NA)
Adriamycin/Cisplatin	1	213.2 (NA)	213.2 (NA)
Total	31	9.3 (3.7–14.9)	19.7 (15.7–23.6)